Laursen, TM, Wahlbeck, K, Hällgren, J, Westman, J, Ösby, U, Alinaghizadeh, H et al. Life expectancy and death by diseases of the circulatory system in patients with bipolar disorder or schizophrenia in the nordic countries. PLoS One
2013; 8: 1–7.
Zimmet, P, Magliano, D, Matsuzawa, Y, Alberti, G, Shaw, J. The metabolic syndrome: a global public health problem and a new definition. J Atheroscler Thromb
2005; 12: 295–300.
Hert, M, Correll, CU, Bobes, J, Cetkovich-Bakmas, M, Cohen, D, Asai, I, et al. Physical illness in patients with severe mental disorders. I. prevalence, impact of medications and disparities in health care. World Psychiatry
2011; 10: 52–77.
McEvoy, JP, Meyer, JM, Goff, DC, Nasrallah, HA, Davis, SM, Sullivan, L, et al. Prevalence of the metabolic syndrome in patients with schizophrenia: Baseline results from the clinical antipsychotic trials of intervention effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III. Schizophr Res
2005; 80: 19–32.
McGinty, EE, Baller, J, Azrin, ST, Juliano-Bult, D, Daumit, GL. Interventions to address medical conditions and health-risk behaviors among persons with serious mental illness: a comprehensive review. Schizophr Bull
2016; 42: 96–124.
Bruins, J, Jörg, F, Bruggeman, R, Slooff, C, Corpeleijn, E, Pijnenborg, M. The effects of lifestyle interventions on (long-term) weight management, cardiometabolic risk and depressive symptoms in people with psychotic disorders: a meta-analysis. PloS One
2014; 9: e112276.
Cabassa, L, Ezell, J, Lewis-Fernández, R. Lifestyle interventions for adults with serious mental illness: a systematic literature review. Psychiatr Serv
2010; 61: 774–82.
Daumit, GL, Dickerson, FB, Wang, N, Dalcin, A, Jerome, GJ, Anderson, CAM, et al. A behavioral weight-loss intervention in persons with serious mental illness. N Engl J Med
2013; 368: 1594–602.
Brar, JS, Ganguli, R, Pandina, G, Turkoz, I, Berry, S, Mahmoud, R. Effects of behavioral therapy on weight loss in overweight and obese patients with schizophrenia or schizoaffective disorder. J Clin Psychiatry
2005; 66: 205–12.
Alvarez-Jimenez, M, Gonzalez-Blanch, C, Vazquez-Barquero, JL, Pérez-Iglesias, R, Martínez-García, O, Pérez-Pardal, T, et al. Attenuation of antipsychotic-induced weight gain with early behavioral intervention in drug-naive first-episode psychosis patients: a randomized controlled trial. J Clin Psychiatry
2006; 67: 1253–60.
Wu, R, Zhao, J, Jin, H, Shao, P, Fang, MS, Guo, XF, et al. Lifestyle intervention and metformin for treatment of antipsychotic-induced weight gain: a randomized controlled trial. JAMA
2008; 299: 185–93.
Hassapidou, M, Papadimitriou, K, Athanasiadou, N, Tokmakidou, V, Pagkalos, I, Vlahavas, G, et al. Changes in body weight, body composition and cardiovascular risk factors after long-term nutritional intervention in patients with severe mental illness: an observational study. BMC Psychiatry
2011; 11: 31–8.
Swinburn, B, Egger, G, Raza, F. Dissecting obesogenic environments: the development and application of a framework for identifying and prioritizing environmental interventions for obesity. Prev Med
1999; 29: 563–70.
Faulkner, G, Cohn, TA. Pharmacologic and nonpharmacologic strategies for weight gain and metabolic disturbance in patients treated with antipsychotic medications. Can J Psychiatry
2006; 51: 502–11.
Cohn, T, Grant, S, Faulkner, GE. Schizophrenia and obesity: addressing obesogenic environments in mental health settings. Schizophr Res
2010; 121: 277–8.
Melamed, Y, Stein-Reisner, O, Gelkopf, M, Levi, G, Sivan, T, Ilievici, G, et al. Multi-modal weight control intervention for people with persistent mental disorders. Psychiatr Rehabil J
2008; 31: 194–200.
Sbrocco, T, Nedegaard, RC, Stone, JM, Lewis, EL. Behavioral choice treatment promotes continuing weight loss: preliminary results of a cognitive-behavioral decision-based treatment for obesity. J Consult Clin Psychol
1999; 67: 260.
Looijmans, A, Jörg, F, Schoevers, RA, Bruggeman, R, Stolk, RP, Corpeleijn, E. Changing the obesogenic environment of severe mentally ill residential patients: ELIPS, a cluster randomised study design. BMC Psychiatry
2014; 14: 293.
Treweek, S, Zwarenstein, M. Making trials matter: pragmatic and explanatory trials and the problem of applicability. Trials
2009; 10: 9.
Bruins, J, Pijnenborg, MG, Bartels-Velthuis, AA, Visser, E, van den Heuvel, ER, Bruggeman, R, et al. Cannabis use in people with severe mental illness: the association with physical and mental health – a cohort study. A pharmacotherapy monitoring and outcome survey study. J Psychopharmacol
2016; 30: 354–62.
Grundy, SM, Cleeman, JI, Daniels, SR, Donato, KA, Eckel, RH, Franklin, BA, et al. Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation
2005; 112: 2735–52.
Forouhi, N, Balkau, B, Borch-Johnsen, K, Dekker, J, Glumer, C, Qiao, Q, et al. The threshold for diagnosing impaired fasting glucose: a position statement by the European diabetes epidemiology group. Diabetologia
2006; 49: 822–7.
International Expert Committee. International expert committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care
2009; 32: 1327–34.
Eisenmann, JC. On the use of a continuous metabolic syndrome score in pediatric research. Cardiovasc Diabetol
2008; 7: 17–22.
Bakker, SJ, Gansevoort, RT, de Zeeuw, D. Metabolic syndrome: a fata morgana?
Nephrol Dial Transplant
2007; 22: 15–20.
Farin, HM, Abbasi, F, Reaven, GM. Comparison of body mass index versus waist circumference with the metabolic changes that increase the risk of cardiovascular disease in insulin-resistant individuals. Am J Cardiol
2006; 98: 1053–6.
Fox, KA, Despres, JP, Richard, AJ, Brette, S, Deanfield, JE, IDEA Steering Committee and National Coordinators. Does abdominal obesity have a similar impact on cardiovascular disease and diabetes? A study of 91,246 ambulant patients in 27 European countries. Eur Heart J
2009; 30: 3055–63.
Pischon, T, Boeing, H, Hoffmann, K, Bergmann, M, Schulze, MB, Overvad, K, et al. General and abdominal adiposity and risk of death in Europe. N Engl J Med
2008; 359: 2105–20.
Forsberg, KA, Björkman, T, Sandman, PO, Sandlund, M. Physical health – a cluster randomized controlled lifestyle intervention among persons with a psychiatric disability and their staff. Nord J Psychiatry
2008; 62: 486–95.
Hjorth, P, Davidsen, AS, Kilian, R, Pilgaard Eriksen, S, Jensen, SO, S⊘rensen, Hø, et al. Improving the physical health of long-term psychiatric inpatients. Aust NZ J Psychiatry
2014; 48: 861–70.
Roumen, C, Blaak, EE, Corpeleijn, E. Lifestyle intervention for prevention of diabetes: Determinants of success for future implementation. Nutr Rev
2009; 67: 132–46.
Goodyear, P, Laurie, J, Kahn, M, Barbara, B. Exercise, glucose transport, and insulin sensitivity. Annu Rev Med
1998; 49: 235–61.
McKibbin, CL, Patterson, TL, Norman, G, Patrick, K, Jin, H, Roesch, S, et al. A lifestyle intervention for older schizophrenia patients with diabetes mellitus: a randomized controlled trial. Schizophr Res
2006; 86: 36–44.
Kaczynski, AT, Henderson, KA. Environmental correlates of physical activity: a review of evidence about parks and recreation. Leis Sci
2007; 29: 315–54.
Doucette, PA. Walk and talk: an intervention for behaviorally challenged youths. Adolescence
2004; 39: 373–88.
Lean, M, Leavey, G, Killaspy, H, Green, N, Harrison, I, Cook, S, et al. Barriers to the sustainability of an intervention designed to improve patient engagement within NHS mental health rehabilitation units: a qualitative study nested within a randomised controlled trial. BMC Psychiatry
2015; 15: 209.
Bradshaw, T, Wearden, A, Marshall, M, Warburton, J, Husain, N, Pedley, R, et al. Developing a healthy living intervention for people with early psychosis using the medical research council's guidelines on complex interventions: Phase 1 of the HELPER-InterACT programme. Int J Nurs Stud
2012; 49: 398–406.